Karissa Hodges
Physician Assistant · Los Angeles, CANPI 1053668046
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,515 of the $16,805 with a category attached, or 68.5%. 45 manufacturers reported payments, led by UCB, Inc. at 40.5% of the total. Reporting peaked in 2024 at $7,653 and has fallen 66.1% since, to $2,595 in 2025. Among physician assistant clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 491 payments — averaging $34.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$7K
- AbbVie$2K
- Supernus Pharmaceuticals, Inc.$1K
- SK Life Science, Inc.$810
- Neurelis, Inc.$751
- Lundbeck LLC$546
- plus $5K from 39 others
What the payments were for
- Consulting fees$2,95018%
- Speaking & faculty fees$1,0006%
- Travel & lodging$1,3298%
- Food & beverage$11,51569%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Fintepla$4,359
- OXTELLAR XR$1,000
- QELBREE$250
- TYSABRI$150
- UBRELVY$122
How this compares
$16,805 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EpidiolexCannabidiol (Cbd) | 13 | $35,483 |
| XcopriCenobamate | 16 | $29,119 |
| ValtocoDiazepam | 11 | $7,933 |
| ConcertaMethylphenidate Hcl | 11 | $5,134 |
| Clobazam | 16 | $2,567 |
| Lacosamide | 12 | $1,214 |
| Atomoxetine Hcl | 12 | $798 |
| Levetiracetam | 15 | $612 |
| Lamotrigine | 18 | $162 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| SK Life Science, Inc.Xcopri | $810 | $29,11916 claims |
| Neurelis, Inc.Valtoco | $751 | $7,93311 claims |
| Johnson & JohnsonConcerta | $85 | $5,13411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Los Angeles
- Asia SullivanLos Angeles$61K
- Felipe FindleyLos Angeles$51K
- Melissa GriffinLos Angeles$39K
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.